Previous 10 | Next 10 |
KODOCARE Pharmacy's Chad Kodiak, RPh, PharmD, Receives Champion Of Humanistic Care Recognition At Arnold P. Gold Foundation Annual Gala The University of St. Francis Leach College of Nursing representatives, Dr. Anthony Fauci, Dr. Wayne Riley and Dr. Eric Topol amongst others ho...
Curis Announces Positive Updated Data from Ongoing Phase 1/2 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes - Updated data show marrow blast reductions in 10 out of 12 evaluable patients with elevated bla...
Health Enterprise Partners Completes Recapitalization of AllyAlign Health PR Newswire NEW YORK , June 11, 2021 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, today announced that it has completed a significant recapitalizati...
USA Swimming Partners with BD to Provide COVID-19 Screening for the Olympic Trials and Other Competitive Swimming Events PR Newswire FRANKLIN LAKES, N.J. , June 11, 2021 /PRNewswire/ -- USA Swimming, the national governing body for the sport of swimming in ...
Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou PR Newswire BEIJING , June 11, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cance...
Excelera Network Welcomes BJC HealthCare BJC HealthCare, one of the largest non-profit health care organizations in the U.S., becomes first Excelera Network member in Missouri PR Newswire MINNEAPOLIS , June 11, 2021 /PRNewswire/ -- BJC HealthCare has entered ...
SpliSense Presents Preclinical Data for SPL23-ASO, mRNA-Altering Drug Candidate for the Treatment of Cystic Fibrosis, at the European Cystic Fibrosis Conference Data show that SPL23-ASO, targeting the W1282X nonsense mutation, enables production of a functional cystic fibrosis t...
Ryvu Therapeutics Presents Positive Phase I Data for RVU120 at the Virtual 26th Annual Congress of the European Hematology Association. Phase I/II Data for SEL24 (MEN1703) presented by development partner Menarini RVU120 (CDK8/19 inhibitor): Acceptable safety profile and two cli...
Bergenbio Presents Encouraging Updated Preliminary Data From Phase Ii Study In Relapsed Aml Patients At Eha Virtual Meeting Encouraging updated preliminary survival data more than double standard of care reported in relapsed AML patients PR Newswire BERGEN, Norway ...
OxThera reports results from Phase 3 ePHex study with Oxabact in primary hyperoxaluria patients with maintained kidney function PR Newswire STOCKHOLM , June 11, 2021 /PRNewswire/ -- OxThera AB, a privately-held biopharmaceutical company dedicated to improving t...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 33.8% to $0.0788 on volume of 1,221,538,672 shares Akoustis Technologies Inc. (AKTS) rose 128.8% to $0.3151 on volume of 536,119,838 shares Crown Electrokinetics Corp. (CRKN) rose 3.1% t...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 16.4% to $0.199 on volume of 720,586,242 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 74.8% to $1.8 on volume of 682,362,254 shares Pineapple Energy Inc. (PEGY) rose 80.3% to $0.1...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 37.1% to $0.2344 on volume of 300,511,226 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 78.2% to $1.835 on volume of 218,102,513 shares Greenwave Technology Solutions Inc. (GWAV) r...